The population of individuals aged 75-84 is expected to increase by 51.5%
Will establish up to eight new centers within the next year
Researchers highlight urgent need for investment in global radiotherapy infrastructure
Bringing abelacimab, investigational Factor XI inhibitor, back under Novartis' control
Administrative burden reduction remains a primary driver for adoption
Post-processing of DDR data through Konica Minolta’s Intelligent Workstation allowed for detailed measurements
X1 platform provides biology-guided treatment in real time
Five-year contract is part of the VA’s initiative to improve supply chain efficiency
Inpatient capacity increased by 96 beds, with plans to expand to more than 190
Support development and compatibility of Cubresa BrainPET with MAGNETOM MR systems
February 14, 2025
February 12, 2025
February 12, 2025